Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study.


Journal

Addiction biology
ISSN: 1369-1600
Titre abrégé: Addict Biol
Pays: United States
ID NLM: 9604935

Informations de publication

Date de publication:
11 2020
Historique:
received: 17 04 2019
revised: 25 07 2019
accepted: 26 08 2019
pubmed: 21 11 2019
medline: 29 9 2021
entrez: 21 11 2019
Statut: ppublish

Résumé

While imaging studies have demonstrated volumetric differences in subcortical structures associated with dependence on various abused substances, findings to date have not been wholly consistent. Moreover, most studies have not compared brain morphology across those dependent on different substances of abuse to identify substance-specific and substance-general dependence effects. By pooling large multinational datasets from 33 imaging sites, this study examined subcortical surface morphology in 1628 nondependent controls and 2277 individuals with dependence on alcohol, nicotine, cocaine, methamphetamine, and/or cannabis. Subcortical structures were defined by FreeSurfer segmentation and converted to a mesh surface to extract two vertex-level metrics-the radial distance (RD) of the structure surface from a medial curve and the log of the Jacobian determinant (JD)-that, respectively, describe local thickness and surface area dilation/contraction. Mega-analyses were performed on measures of RD and JD to test for the main effect of substance dependence, controlling for age, sex, intracranial volume, and imaging site. Widespread differences between dependent users and nondependent controls were found across subcortical structures, driven primarily by users dependent on alcohol. Alcohol dependence was associated with localized lower RD and JD across most structures, with the strongest effects in the hippocampus, thalamus, putamen, and amygdala. Meanwhile, nicotine use was associated with greater RD and JD relative to nonsmokers in multiple regions, with the strongest effects in the bilateral hippocampus and right nucleus accumbens. By demonstrating subcortical morphological differences unique to alcohol and nicotine use, rather than dependence across all substances, results suggest substance-specific relationships with subcortical brain structures.

Identifiants

pubmed: 31746534
doi: 10.1111/adb.12830
pmc: PMC7237314
mid: NIHMS1048424
doi:

Substances chimiques

Ethanol 3K9958V90M
Methamphetamine 44RAL3456C
Nicotine 6M3C89ZY6R
Cocaine I5Y540LHVR

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12830

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA014100
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024925
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH017140
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH116147
Pays : United States
Organisme : NIDA NIH HHS
ID : PL1 DA024859
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG058507
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : NIAAA NIH HHS
ID : L30 AA024302
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA020709
Pays : United States
Organisme : NIAAA NIH HHS
ID : RC1 AA019036
Pays : United States
Organisme : NIDA NIH HHS
ID : RL1 DA024853
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AA000123
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA013892
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA024635
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH073526
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA015179
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR000865
Pays : United States
Organisme : NIDA NIH HHS
ID : P20 DA022539
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA016599
Pays : United States
Organisme : NIDA NIH HHS
ID : K25 DA040032
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA021449
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA023248
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA047119
Pays : United States
Organisme : NIAAA NIH HHS
ID : R00 AA025401
Pays : United States
Organisme : CIHR
Pays : Canada
Organisme : NIDA NIH HHS
ID : F30 DA021961
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA018307
Pays : United States

Informations de copyright

© 2019 Society for the Study of Addiction.

Références

Gigascience. 2014 Nov 25;3:29
pubmed: 25793106
Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6
pubmed: 2308954
Brain Imaging Behav. 2014 Jun;8(2):153-82
pubmed: 24399358
Int J Environ Res Public Health. 2010 Oct;7(10):3760-91
pubmed: 21139859
J Neurosci. 2007 Aug 1;27(31):8202-18
pubmed: 17670967
Neuroscience. 1989;28(2):275-90
pubmed: 2522167
Drug Alcohol Depend. 2015 Sep 1;154:1-13
pubmed: 26072219
Eur J Neurosci. 1994 Oct 1;6(10):1596-604
pubmed: 7850023
Curr Psychiatry Rep. 2014 Dec;16(12):513
pubmed: 25308385
Indian J Psychiatry. 2007 Apr;49(2):85-90
pubmed: 20711388
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Neuron. 2004 Nov 18;44(4):729-40
pubmed: 15541319
Nat Commun. 2015 Dec 14;6:10088
pubmed: 26657320
Nat Rev Neurosci. 2011 Sep 07;12(10):585-601
pubmed: 21897434
Hippocampus. 2009 Jun;19(6):558-64
pubmed: 19405132
Neuron. 2010 Jan 14;65(1):7-19
pubmed: 20152109
Am J Drug Alcohol Abuse. 2015;41(4):290-9
pubmed: 26125488
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):59-71
pubmed: 30706169
Drug Alcohol Depend. 2013 Dec 1;133(2):704-11
pubmed: 24051060
Neuroimage. 2017 Jul 15;155:370-382
pubmed: 28479476
Brain Res Mol Brain Res. 2005 Apr 27;135(1-2):104-11
pubmed: 15857673
PLoS One. 2011;6(11):e27440
pubmed: 22076160
Neuroimage. 2012 Nov 15;63(3):1134-42
pubmed: 22846656
Brain Res. 2009 Oct 13;1293:61-75
pubmed: 19332030
Dialogues Clin Neurosci. 2016 Mar;18(1):7-21
pubmed: 27069376
Addiction. 2001 Nov;96(11):1603-14
pubmed: 11784457
Mol Psychiatry. 2017 Jan;22(1):68-75
pubmed: 27001613
Curr Addict Rep. 2016 Jun 1;3(2):182-188
pubmed: 27175326
PLoS Med. 2008 Jul 1;5(7):e141
pubmed: 18597549
Neurobiol Learn Mem. 2007 May;87(4):688-92
pubmed: 17337218
J Comp Neurol. 1995 Aug 14;359(1):154-94
pubmed: 8557845
Neuroimage. 2011 Jun 15;56(4):1993-2010
pubmed: 21440071
Int J Neuropsychopharmacol. 2008 Jun;11(4):497-508
pubmed: 18047756
Curr Neuropharmacol. 2008 Mar;6(1):39-54
pubmed: 19305787
Mol Psychiatry. 2016 Jun;21(6):806-12
pubmed: 26122586
Biochem Pharmacol. 2009 Oct 1;78(7):756-65
pubmed: 19540212
Behav Brain Sci. 2008 Aug;31(4):415-37; discussion 437-87
pubmed: 18662461
JAMA Psychiatry. 2016 Jan;73(1):39-47
pubmed: 26580136
Eur J Neurosci. 2006 Sep;24(6):1744-50
pubmed: 17004938
Neurosci Biobehav Rev. 2015 Oct;57:271-83
pubmed: 26341938
Biol Psychiatry. 2004 Jan 1;55(1):77-84
pubmed: 14706428
Neuropharmacology. 2009;56 Suppl 1:18-31
pubmed: 18725236
Neurosci Biobehav Rev. 2016 Jul;66:92-103
pubmed: 27108216
Hippocampus. 2009 Jun;19(6):549-57
pubmed: 19405131
Curr Opin Behav Sci. 2017 Feb;13:13-18
pubmed: 28094824
Behav Brain Funct. 2016 Jun 02;12(1):16
pubmed: 27251183
Neuroimage. 2007 Oct 15;38(1):43-56
pubmed: 17825583
Biol Psychiatry. 2001 Jun 1;49(11):894-905
pubmed: 11377407
Soc Cogn Affect Neurosci. 2015 Dec;10(12):1615-22
pubmed: 25969533
Ann N Y Acad Sci. 2008 Oct;1141:1-21
pubmed: 18991949
Alcohol Clin Exp Res. 1992 Dec;16(6):1078-89
pubmed: 1471762
Am J Psychiatry. 2019 Feb 1;176(2):119-128
pubmed: 30336705
Prog Brain Res. 2016;224:203-23
pubmed: 26822360
Neurosci Biobehav Rev. 2015 Jul;54:29-37
pubmed: 25862940
Addict Biol. 2012 Jul;17(4):817-25
pubmed: 21392170

Auteurs

Yann Chye (Y)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.

Scott Mackey (S)

Departments of Psychiatry, University of Vermont, Burlington, VT, USA.

Boris A Gutman (BA)

Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.

Christopher R K Ching (CRK)

Department of Neurology, Keck School of Medicine, Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA.

Albert Batalla (A)

Department of Psychiatry, University Medical Centre Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
Department of Psychiatry and Psychology, Hospital Clinic, IDIBAPS, CIBERSAM, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.

Sara Blaine (S)

Departments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.

Samantha Brooks (S)

Faculty of Health, School of Psychology, Liverpool John Moores University, L3 3AF, Liverpool UK.
Department of Neuroscience, Section of Functional Pharmacology, Uppsala University, 75240, Sweden.

Elisabeth C Caparelli (EC)

Neuroimaging Research Branch, Intramural Research Program, National Institute of Drug Abuse, Baltimore, MD, USA.

Janna Cousijn (J)

Department of Developmental Psychology, University of Amsterdam, The Netherlands.

Alain Dagher (A)

McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

John J Foxe (JJ)

Department of Neuroscience & The Ernest J. Del Monte Institute for Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Anna E Goudriaan (AE)

Amsterdam UMC, Department of Psychiatry, Amsterdam Institute for Addiction Research, University of Amsterdam, Amsterdam, The Netherlands.
Department of Research and Quality of Care, Arkin Mental Health Care, Amsterdam, The Netherlands.

Robert Hester (R)

Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.

Kent Hutchison (K)

Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.

Neda Jahanshad (N)

Department of Neurology, Keck School of Medicine, Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA.

Anne M Kaag (AM)

Department of Developmental Psychology, University of Amsterdam, The Netherlands.

Ozlem Korucuoglu (O)

Department of Psychiatry, Washington University School of Medicine, Saint Louis, MO, USA.

Chiang-Shan R Li (CR)

Departments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.

Edythe D London (ED)

Jane and Terry Semel Institute of Neuroscience and Human Behavior, David Geffen School of Medicine, Universityof California at Los Angeles, Los Angeles, CA, USA.

Valentina Lorenzetti (V)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.
School of Psychology, Faculty of Health Sciences, Australian Catholic University, Melbourne, Victoria, Australia.

Maartje Luijten (M)

Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.

Rocio Martin-Santos (R)

Department of Psychiatry and Psychology, Hospital Clinic, IDIBAPS, CIBERSAM, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.

Shashwath A Meda (SA)

Olin Neuropsychiatry Research Center, Hartford Hospital/IOL, Hartford, CT, USA.

Reza Momenan (R)

Clinical NeuroImaging Research Core, Division of Intramural Clinical and BiologicalResearch, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MD, USA.

Angelica Morales (A)

Jane and Terry Semel Institute of Neuroscience and Human Behavior, David Geffen School of Medicine, Universityof California at Los Angeles, Los Angeles, CA, USA.

Catherine Orr (C)

Departments of Psychiatry, University of Vermont, Burlington, VT, USA.

Martin P Paulus (MP)

VA San Diego Healthcare System and Department of Psychiatry, University of California San Diego, CA, USA.
Laureate Institute for Brain Research, Tulsa, OK, USA.

Godfrey Pearlson (G)

Departments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.

Liesbeth Reneman (L)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.

Lianne Schmaal (L)

Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Rajita Sinha (R)

Departments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.

Nadia Solowij (N)

School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.
The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), New Lambton Heights, New South Wales, Australia.

Dan J Stein (DJ)

SA MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Elliot A Stein (EA)

Neuroimaging Research Branch, Intramural Research Program, National Institute of Drug Abuse, Baltimore, MD, USA.

Deborah Tang (D)

McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Anne Uhlmann (A)

Department of Psychiatry and Mental Health, Faculty of Health Sciences University of Cape Town, South Africa.

Ruth van Holst (R)

Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands.

Dick J Veltman (DJ)

Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.

Antonio Verdejo-Garcia (A)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.

Reinout W Wiers (RW)

Addiction Development and Psychopathology (ADAPT) Lab, University of Amsterdam, Amsterdam, The Netherlands.

Murat Yücel (M)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.

Paul M Thompson (PM)

Department of Neurology, Keck School of Medicine, Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA.

Patricia Conrod (P)

Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Canada.

Hugh Garavan (H)

Departments of Psychiatry, University of Vermont, Burlington, VT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH